IRIS UniCatt

Locatelli, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.926
EU - Europa 4.781
NA - Nord America 3.428
SA - Sud America 2.378
AF - Africa 92
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.621
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.554
US - Stati Uniti d'America 3.324
CN - Cina 2.955
BR - Brasile 2.236
ID - Indonesia 1.246
IT - Italia 1.226
IE - Irlanda 1.147
KR - Corea 1.005
RU - Federazione Russa 669
IN - India 566
DE - Germania 530
SE - Svezia 301
HK - Hong Kong 277
FR - Francia 161
GB - Regno Unito 156
AT - Austria 102
FI - Finlandia 91
CZ - Repubblica Ceca 86
UA - Ucraina 78
NL - Olanda 72
AR - Argentina 58
TR - Turchia 52
MX - Messico 46
IQ - Iraq 42
PL - Polonia 37
JP - Giappone 35
CA - Canada 34
BD - Bangladesh 32
ZA - Sudafrica 30
CO - Colombia 24
CH - Svizzera 22
PK - Pakistan 19
EC - Ecuador 16
ES - Italia 16
MA - Marocco 16
PT - Portogallo 16
UZ - Uzbekistan 16
IR - Iran 15
VE - Venezuela 14
AZ - Azerbaigian 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
SA - Arabia Saudita 11
BE - Belgio 10
EG - Egitto 10
PY - Paraguay 10
KZ - Kazakistan 9
VN - Vietnam 9
PE - Perù 8
BY - Bielorussia 7
KE - Kenya 7
NG - Nigeria 7
UY - Uruguay 7
BG - Bulgaria 6
DZ - Algeria 6
GR - Grecia 6
PH - Filippine 6
BH - Bahrain 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
LV - Lettonia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
BN - Brunei Darussalam 4
HN - Honduras 4
IL - Israele 4
LB - Libano 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
RO - Romania 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
CI - Costa d'Avorio 2
CL - Cile 2
CU - Cuba 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
SI - Slovenia 2
SM - San Marino 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
Totale 21.608
Salva come PNG Salva come JPEG
Città #
Singapore 2.094
Jakarta 1.239
Ashburn 1.218
Dublin 1.146
Hefei 1.074
Seoul 994
Moscow 529
Hyderabad 472
Milan 402
Los Angeles 322
Hong Kong 266
Washington 258
Nuremberg 222
Rome 167
São Paulo 148
Chandler 112
New York 102
Beijing 86
Frankfurt am Main 84
Seattle 83
Chicago 82
Brno 79
Arezzo 64
Rio de Janeiro 59
Pune 56
Helsinki 55
London 53
Belo Horizonte 49
Paris 44
Brasília 42
Shanghai 42
Busto Arsizio 38
Vienna 38
Curitiba 35
Campinas 34
Bologna 32
Düsseldorf 32
Porto Alegre 32
Council Bluffs 31
Jacksonville 31
Santa Clara 31
Guangzhou 29
Munich 25
San Mateo 23
Zhengzhou 23
Nanjing 22
Tokyo 22
Mexico City 21
Ribeirão Preto 21
Boston 19
Florence 18
Fortaleza 18
Salvador 18
Cattolica 17
Lappeenranta 17
Riano 17
Wilmington 17
Genoa 16
Goiânia 16
Guarulhos 16
Maceió 16
Recife 16
Istanbul 15
The Dalles 15
Duque de Caxias 14
Phoenix 14
Tashkent 14
Buenos Aires 13
Caxias do Sul 13
Kraków 13
São Bernardo do Campo 13
São José dos Campos 13
Uberlândia 13
Wuhan 13
Baghdad 12
Baku 12
Chiswick 12
Johannesburg 12
Lawrence 12
Pelotas 12
Piracicaba 12
Praia Grande 12
Santo André 12
Toronto 12
Boardman 11
Changsha 11
Contagem 11
Cuiabá 11
Hangzhou 11
Joinville 11
Kunming 11
Lauterbourg 11
Shenzhen 11
São Gonçalo 11
Xi'an 11
Zurich 11
Amsterdam 10
Bogotá 10
Camaçari 10
Campos dos Goytacazes 10
Totale 12.839
Salva come PNG Salva come JPEG
Nome #
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism 152
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells 113
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 99
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 92
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 79
Proteomics study of peripheral blood mononuclear cells in down syndrome children 78
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. Reply 77
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 75
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma 70
Usefulness of 18F-FDG PET/CT in an Unusual Case of Solid-Pseudopapillary Pancreatic Tumor in Childhood With Aggressive Behavior 69
How I treat relapsed childhood acute lymphoblastic leukemia 69
Advancements and challenges in CAR T cell therapy in autoimmune diseases 67
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS 65
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 60
Identification of a new HLA-B*44 allele, HLA-B*44:02:68, by next generation sequencing 58
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 58
MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs 58
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial 56
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 55
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 53
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity 53
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS 48
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas 46
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 44
TFG binds LC3C to regulate ULK1 localization and autophagosome formation 43
Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior. 43
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) 43
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 42
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL 42
T lymphocytes against solid malignancies: Winning ways to defeat tumours 40
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study 40
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants 40
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 40
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 39
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: An I-BFM Study Group collaboration 39
Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population 39
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia 39
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR) 39
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial 38
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications 38
T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica 38
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience 38
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children 38
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome 38
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant 38
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis 37
T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation 37
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response 37
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 37
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2 37
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies 36
Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellites 35
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies 35
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling 34
CD28.OX40 co-stimulatory combination is high associated activity with of CAR.CD30 long in vivoT persistence cells and 34
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 34
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 34
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study 33
Juvenile myelomonocytic leukemia 33
Donor natural killer cells trigger production of β-2-microglobulin to enhance post–bone marrow transplant immunity 32
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing 32
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia 32
Human γδ T-Cells: From surface receptors to the therapy of high-risk leukemias 32
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model 32
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 32
A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia 31
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) 31
B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies 31
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 31
RNA editing signature during myeloid leukemia cell differentiation 31
Transcription factors involved in tumorigenesis are over-represented in mutated active DNA-binding sites in neuroblastoma A C 30
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters 30
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival among Children with High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial 30
Src nuclear localization and its prognostic relevance in human osteosarcoma 30
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells 30
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome 30
Fak signaling in rhabdomyosarcoma 30
Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses 30
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 30
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol 30
Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene 29
Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients 29
IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma 29
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 29
Antifungal effect of all-trans retinoic acid against aspergillus fumigatus in vitro and in a pulmonary aspergillosis in vivo model 29
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells 29
BRAF V600E inhibitor (vemurafenib) for BRAF V600E mutated low grade gliomas 29
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 29
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome 28
CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia 28
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium 28
Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B-cell acute lymphoblastic leukemia 28
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth 28
An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019 28
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system 28
The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics 28
Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma 28
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies 28
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia 28
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 28
Totale 4.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 12 10
2020/202191 3 12 0 9 11 7 9 2 14 8 16 0
2021/2022142 9 9 5 5 8 6 5 18 7 10 24 36
2022/20231.335 34 47 20 46 27 50 10 38 696 249 68 50
2023/20247.212 213 1.307 421 200 577 1.217 322 292 199 580 692 1.192
2024/202513.792 272 285 1.297 292 668 555 350 433 3.288 1.354 4.998 0
Totale 22.886